Gaetano Morello alive Expert
Joined: 02 Oct 2006 Posts: 1 Location: West Vancouver, BC
|
Posted: Mon Oct 02, 2006 1:33 pm Post subject: |
|
|
Inflammation of the knee joints often points to the most common form of arthritis, known as osteoarthritis (OA). It affects the joints of the hands and the weight-bearing joints, especially those of the hips and knees.
Osteoarthritis involves the destruction of cartilage between the joints that, if unchecked, may eventually lead to hardening, calcification, and deformity. Symptoms usually include mild stiffness on waking or following periods of inactivity and pain that worsens on joint use. OA sufferers may also notice soft-tissue swelling, some possible creaking of the joints on movement, and local tenderness.
Sometimes called wear-and-tear arthritis, OA’s progression relates to the stressors that cause the breakdown of the joint cartilage. These stressors include excessive mobility, joint instability, hormonal factors, altered biochemistry, circulating free radicals, and poor diet.
Drinking plenty of purified water as well as consuming liberal amounts of flavonoid-rich berries will not only hydrate the cartilage but will also provide antioxidant protection. Eliminating foods of the nightshade family (Solanaceae), including tomatoes, potatoes, eggplant, peppers, and tobacco may also have some benefits. These foods contain solanum alkaloids, which can inhibit normal collagen repair in the joints and thus promote the inflammatory degeneration of cartilage.
Take glucosamine sulphate at 500 mg three times a day. This nutrient has been proven in head-to-head, double-blind studies to produce better long-term effects than nonsteroidal anti-inflammatory drugs (NSAIDs) in relieving the pain of OA. Glucosamine sulphate actually provides the building blocks that
help build cartilage, much like proteins help build muscles.
For acute pain relief, a cetylated fatty acid creme may reduce the pain associated with OA in less than 30 minutes. This creme has been shown to be effective in a number of clinical trials and is now showing some real promise in helping patients better deal with OA. |
|